This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM.American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. Journal of Clinical Oncology 27: 3235-3258, No. 19, 1 Jul 2009
Rights and permissions
About this article
Cite this article
New ASCO drug guidelines for breast cancer risk reduction. Pharmacoecon. Outcomes News 580, 3 (2009). https://doi.org/10.2165/00151234-200905800-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905800-00006